High-resolution whole-genome association study of Parkinson disease - PubMed (original) (raw)

High-resolution whole-genome association study of Parkinson disease

Demetrius M Maraganore et al. Am J Hum Genet. 2005 Nov.

Abstract

We performed a two-tiered, whole-genome association study of Parkinson disease (PD). For tier 1, we individually genotyped 198,345 uniformly spaced and informative single-nucleotide polymorphisms (SNPs) in 443 sibling pairs discordant for PD. For tier 2a, we individually genotyped 1,793 PD-associated SNPs (P<.01 in tier 1) and 300 genomic control SNPs in 332 matched case-unrelated control pairs. We identified 11 SNPs that were associated with PD (P<.01) in both tier 1 and tier 2 samples and had the same direction of effect. For these SNPs, we combined data from the case-unaffected sibling pair (tier 1) and case-unrelated control pair (tier 2) samples and employed a liberalization of the sibling transmission/disequilibrium test to calculate odds ratios, 95% confidence intervals, and P values. A SNP within the semaphorin 5A gene (SEMA5A) had the lowest combined P value (P=7.62 x 10(-6)). The protein encoded by this gene plays an important role in neurogenesis and in neuronal apoptosis, which is consistent with existing hypotheses regarding PD pathogenesis. A second SNP tagged the PARK11 late-onset PD susceptibility locus (P=1.70 x 10(-5)). In tier 2b, we also selected for genotyping additional SNPs that were borderline significant (P<.05) in tier 1 but that tested a priori biological and genetic hypotheses regarding susceptibility to PD (n=941 SNPs). In analysis of the combined tier 1 and tier 2b data, the two SNPs with the lowest P values (P=9.07 x 10(-6); P=2.96 x 10(-5)) tagged the PARK10 late-onset PD susceptibility locus. Independent replication across populations will clarify the role of the genomic loci tagged by these SNPs in conferring PD susceptibility.

PubMed Disclaimer

Comment in

References

Web Resources

    1. Entrez Gene, http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene
    1. GeneCards, http://bioinfo.weizmann.ac.il/cards/index.shtml
    1. Online Mendelian Inheritance in Man (OMIM), http://www.ncbi.nlm.nih.gov/Omim/ (for PD, SNCA, parkin, UCHL1, MAPT, DJ1, PINK1, PARK3, PARK8, PARK9, PARK10, PARK11, LRRK2, SEMA5A, GALNT3, and PRDM2)
    1. SeattleSNPs, http://pga.gs.washington.edu/ (for PGA)

References

    1. Artigiani S, Conrotto P, Fazzari P, Gilestro GF, Barberis D, Giordano S, Comoglio PM, Tamagnone L (2004) Plexin-B3 is a functional receptor for semaphorin 5A. EMBO Rep 5:710–71410.1038/sj.embor.7400189 - DOI - PMC - PubMed
    1. Bacanu S-A, Devlin B, Roeder K (2000) The power of genomic control. Am J Hum Genet 66:1933–1944 - PMC - PubMed
    1. Barzilai A, Zilkha-Falb R, Daily D, Stern N, Offen D, Ziv I, Melemed E, Shirvan A (2000) The molecular mechanism of dopamine-induced apoptosis: identification and characterization of genes that mediate dopamine toxicity. J Neural Transm Suppl 60:59–76 - PubMed
    1. Benedetti MD, Maraganore DM, Bower JH, McDonnell SK, Peterson BJ, Ahlskog JE, Schaid DJ, Rocca WA (2001) Hysterectomy, menopause, and estrogen use preceding Parkinson’s disease. Mov Disord 16:830–83710.1002/mds.1170 - DOI - PubMed
    1. Bonifati V, Rizzu P, van Baren MJ, Schaap O, Breedveld GJ, Krieger E, Dekker MCJ, Squitieri F, Ibanez P, Joosse M, van Dongen JW, Vanacore N, van Swieten JC, Brice A, Meco G, van Duijn CM, Oostra BA, Heutink P (2003) Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299:256–25910.1126/science.1077209 - DOI - PubMed

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources